Find what’s really holding growth back. Fix what matters first.
For B2B SaaS founders and leadership teams when growth is becoming harder to explain—and the next move could be expensive. Before you hire, restructure, change compensation or add tooling, identify the real constraint and the few priorities most likely to change the system.
Discuss your growth question →
Turn competing explanations into focused commercial decisions.
Find the constraint
Separate visible symptoms from the mechanism actually limiting growth.
Prioritise hard
Identify the few moves with disproportionate impact, and what not to prioritise.
Triangulate evidence
Combine leadership perspectives, operating evidence and observed behaviour.
Avoid costly wrong moves
Reduce wasted capital, time and organisational energy fixing the wrong thing.
When the explanation is uncertain, action becomes expensive.
Senior hiring
Before hiring a CRO, VP Sales or adding more commercial headcount.
Organisation redesign
Before restructuring roles, territories, incentives or leadership responsibilities.
Systems investment
Before buying tooling or introducing another process or transformation programme.
The next growth bet
Before entering a new segment, accelerating investment or committing another quarter.
Commercial Scale Diagnostic™
An independent diagnosis of the commercial system designed to reveal the root constraint, why it exists, and what to fix first.
The work examines the commercial system across seven connected lenses: strategic direction, commercial strategy, revenue execution, commercial leadership & organisation, customer value & market reality, the commercial operating system, and scale readiness & transformation. Interviews, evidence review and selected observations are triangulated to distinguish symptoms from causes and identify the few priorities with disproportionate impact.
A clear view of what is actually limiting growth—not merely the most visible symptom.
Why the constraint exists and how the connected parts of the commercial system reinforce it.
Two or three findings and priorities with disproportionate impact, translated into leadership decisions.
What not to fund, fix or escalate yet—so time, capital and organisational energy stay focused.
You are not paying for more analysis.
You are paying to avoid making the next expensive commercial decision based on the wrong explanation.
A single mis-hire, unnecessary reorganisation, wrong tooling investment or lost quarter can cost far more than the Diagnostic. Its value is better commercial judgment: where to act, what to sequence, and what to deliberately leave alone.
From distributed evidence to the few decisions that matter.
Fragmented perspectives, operating evidence and observed behaviour are converted into decision intelligence through one disciplined sequence.
Frame
Define the growth ambition, current stage and question leadership needs answered.
Examine
Review evidence, speak with key stakeholders and observe the commercial system in practice.
Diagnose
Separate symptoms from mechanisms, identify the root constraint and test confidence in the conclusion.
Decide
Clarify what to fix first, what can wait, and the few next moves most likely to change the system.
Support follows the evidence—not a predetermined programme.
The Diagnostic stands alone and leadership can implement the findings internally. Further support is recommended only where it would materially improve execution.
Focused intervention
Targeted support against a validated commercial priority.
Fractional commercial leadership
Hands-on leadership through a defined transition or capability gap.
Leadership development
Executive coaching connected directly to the identified business need.
Team development
Focused workshops that strengthen the system around the priority.
Independent perspective. Focused commercial judgment.
MV Advisory combines commercial discipline, systems thinking and executive coaching to help leadership teams see the commercial system clearly before deciding where to intervene.
The work is deliberately boutique: a small number of leadership teams, evidence-led recommendations and no predetermined programme or long list of generic fixes.